Randomized Study of Train the Colonoscopy Leaders Course Versus Audit and Feedback on Colonoscopy Quality Indicators
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01667198 |
Recruitment Status :
Completed
First Posted : August 17, 2012
Last Update Posted : April 16, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Professional societies recommend that endoscopists measure their ceacal intubation rate, adenoma detection rate as indicators of the screening colonoscopy quality. However, it is uncertain how to improve adenoma detection rate and reduce inter-endoscopists' variability in the detection of adenomas. The investigators hypothesize that a hands-on-training intervention tailored to the results of environmental assessment and audit on colonoscopy quality indicators results in higher adenoma detection rate improvement than simple audit and feedback. The investigators further hypothesize that by training the leaders of the screening centres, the effect of the intervention will be further disseminated among other endoscopists from the participating centers, and will thus result in additional increase in individual adenoma detection rate.
The primary aim is to compare the impact on adenoma detection rate of two screening colonoscopy improvement programs:
- Tailored training intervention.
- Audit feedback on colonoscopy quality indicators.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Colorectal Cancer | Procedure: Train the leaders course Behavioral: Audit and feedback | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | Quality Improvement in Screening Colonoscopy - a Randomized Trial of Tailored Training Intervention Versus Simple Feedback on the Quality Indicators. |
Study Start Date : | July 2012 |
Actual Primary Completion Date : | December 2012 |
Actual Study Completion Date : | December 2012 |
Arm | Intervention/treatment |
---|---|
Experimental: Train the leaders course |
Procedure: Train the leaders course
Screening centre leaders randomized to the training intervention group will be invited to take part in a train-the-leaders course. The Train-the-leaders course will consist of three phases: (i) pre-training assessment, (ii) hands-on-training and (iii) post-training evaluation and feedback. The Train-the-leaders course will be run in polish by the team from the Maria Sklodowska-Curie Memorial Cancer Center and Institute on Oncology, Warsaw, which was trained in delivering such intervention by experts from the United Kingdom. |
Active Comparator: Audit and feedback |
Behavioral: Audit and feedback
Screening centre leaders randomized to the feedback group will receive (by e-mail and conventional mail) feedback on their individual screening colonoscopy quality indicators (adenoma detection rate and ceacal intubation rate) measured for the 2011 edition of the national screening program. The results will be presented in a league table in order to enable comparison with anonymous results of all endoscopists who performed at least 30 colonoscopies within the screening program. In addition, a link to a webpage containing data on individual and overall colonoscopy quality indicators over the last four years of the screening program will be provided. |
- Screening centre leader's adenoma detection rate [ Time Frame: till the end of calendar year after the training intervention ]Adenoma detection rate is defined as the proportion of screened subjects in whom at least one adenomatous lesion is identified.
- Screening center's overall adenoma detection rate [ Time Frame: Till the end of calendar year after the training intervention ]Adenoma detection rate is defined as the proportion of screened subjects in whom at least one adenomatous lesion is identified.
- Screening centre leader's proximal and distal adenoma detection rate [ Time Frame: Till the end of calendar year after the training intervention ]Adenoma detection rate is defined as the proportion of screened subjects in whom at least one adenomatous lesion is identified.
- Screening centre's non-polypoid lesion detection rate [ Time Frame: Till the end of calendar year after the training intervention ]
- Overall screening centre's ceacal intubation rate [ Time Frame: Till the end of calendar year after the training intervention ]Ceacal intubation is defined as the passage of the colonoscope tip to a point proximal to the ileoceacal valve and visualization of the entire ceacum.
- Screening centre leader's withdrawal technique [ Time Frame: Till the end of calendar year after the training intervention ]Withdrawal technique assessed by a trained endoscopy nurse

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- screening center leading colonoscopist
- at least 30 screening colonoscopies in the 2011 edition of the screening program
- adenoma detection rate lower than 25%
Exclusion Criteria:
- lack of participation in the 2012 edition of the screening program

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01667198
Poland | |
The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology | |
Warsaw, Poland, 02-781 |
Principal Investigator: | Michal F. Kaminski, MD, PhD | The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology | |
Study Chair: | Jaroslaw Regula, MD, PhD | The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland |
Responsible Party: | Maria Sklodowska-Curie Institute - Oncology Center |
ClinicalTrials.gov Identifier: | NCT01667198 |
Other Study ID Numbers: |
IP2010016270 |
First Posted: | August 17, 2012 Key Record Dates |
Last Update Posted: | April 16, 2014 |
Last Verified: | April 2014 |
Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |